Phase 2/3 Clinical Trials
23 trials are at Phase 2/3 in the index.
Trials (23)
- 68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment Phase 2/3 · Andrei Iagaru
- Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix Phase 2/3 · United States Naval Medical Center, San Diego
- Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome Phase 2/3 · Anne Comi, MD
- Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Phase 2/3 · Ludwig-Maximilians - University of Munich
- Comparing TIVA Using Propofol or Dexmedetomidine Versus Sevoflurane During Anaesthesia of Children Undergoing Bone-Marrow Aspiration Phase 2/3 · Alexandria University
- Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma Phase 2/3 · Australasian Gastro-Intestinal Trials Group
- Intravesical Adjuvant Electromotive Mitomycin-C Phase 2/3 · University of Rome Tor Vergata
- Effect of Tramadol Versus Morphine on PD1 and PD1-ligand in Patients With Chronic Cancer Pain Phase 2/3 · Assiut University
- Toripalimab or Placebo as Adjuvant Therapy in Hepatocellular Carcinoma After Radical Resection Phase 2/3 · Shanghai Junshi Bioscience Co., Ltd.
- Surgery Vs Chemoradiation for Oropharyngeal Cancer- A Phase II/III Integrated Design Randomized Control Trial Phase 2/3 · Tata Memorial Centre
- Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma Phase 2/3 · Zefen Xiao
- Long Term Outcomes After EUS-guided Ablation for Cystic Tumors of the Pancreas Phase 2/3 · Asan Medical Center
- NPWT in Patients Undergoing Surgical Procedures for Management of GI Malignancies Phase 2/3 · H. Lee Moffitt Cancer Center and Research Institute
- Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma Phase 2/3 · TuHURA Biosciences, Inc.
- Maekmoondong-tang on Post-operative Cough in Patients With Lung Cancer Phase 2/3 · Seong-Gyu Ko
- MSC and Cyclophosphamide for Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis Phase 2/3 · National Research Center for Hematology, Russia
- The Efficacy and Safety of K-001 in the Treatment of Advanced Pancreatic Cancer Phase 2/3 · RenJi Hospital
- Intravesical AD 32 (Valrubicin) in Patients With Carcinoma in Situ (CIS) of the Bladder Who Have Failed or Have Recurrence Following Treatment With Bacillus Calmette-guerin (BCG) Phase 2/3 · Endo USA Inc., a Keenova Therapeutics Company
- Bevacizumab in Extensive Small Cell Lung Cancer Phase 2/3 · Intergroupe Francophone de Cancerologie Thoracique
- Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers Phase 2/3 · M.D. Anderson Cancer Center
- Lung-MAP: Rilotumumab and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Phase 2/3 · SWOG Cancer Research Network
- Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma Phase 2/3 · Peter Black
- Eradication of Malignant Carcinoma in the Breast Tissue Phase 2/3 · Optimal Health Research
Related landscapes
- Prostate Adenocarcinoma
- PSA Failure
- Recurrent Prostate Carcinoma
- Cervical Intraepithelial Neoplasia
- Sturge-Weber Syndrome
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.